Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Enantioselective total synthesis of the highly selective sphingosine-1-receptor VPC01091 by the Heck desymmetrization of a non-activated cyclopentene-fused spiro-pyrrolidinone.
Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Novel Function of Extracellular Matrix Protein 1 in Suppressing Th17 Cell Development in Experimental Autoimmune Encephalomyelitis.
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
An approach to comprehensive genome and proteome expression analyses in Schwann cells and neurons during peripheral nerve myelin formation.
Increasing Physical Activity and Participation in People with Multiple Sclerosis: A Review.
Demographic-Based Content Analysis of Web-Based Health-Related Social Media.
Impaired Frontolimbic Connectivity and Depressive Symptoms in Patients with Alzheimer's Disease.
Dietary salt intake and time to relapse in paediatric multiple sclerosis.
Electroacupuncture ameliorates memory impairments by enhancing oligodendrocyte regeneration in a mouse model of prolonged cerebral hypoperfusion.
Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study.
Gut microbiome analysis in neuromyelitis optica reveals over-abundance of Clostridium perfringens.
The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats.
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.
[Influence of manganese exposure via intracerebral injection on behavioristics and substantia nigra dopaminergic neurons in rats].
Cervical demyelinating lesion presenting with choreoathetoid movements and dystonia.
Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.
Sphingosine-1-phosphate modulators in inflammatory skin diseases-Lining up for clinical translation.
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.
Mutism Caused by Severe Demyelination in a Patient With Marchiafava-Bignami Disease.

Pages